Tarsus Pharmaceuticals (TARS) Q2 2026 Earnings

May 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.73
-0.54
-0.35
-0.16

Details

Expected EPS
-0.400333
Actual EPS
-0.16
Surprise EPS
0.24
Surprise Percent
+60.03%

Description

⁨Tarsus Pharmaceuticals⁩ (⁦TARS⁩) has reported earnings of ⁦-0.16⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts